# US regulators back multi-cancer blood test, but Hong Kong doctors remain cautious

https://mins.news/en/item/72083

- South China Morning Post, 2026-09-24 10:05 UTC
- Health
- Original: https://www.scmp.com/business/companies/article/3368665/us-regulators-back-multi-cancer-blood-test-hong-kong-doctors-remain-cautious?utm_source=rss_feed

> US regulators have endorsed technology designed to detect multiple cancers from a single blood draw for the first time. An FDA panel voted in favour of Grail’s Galleri test, but experts say wider use in Hong Kong still faces hurdles as doctors question its clinical value.

## Related coverage

- [Blood test for cancer nears approval](https://mins.news/en/video/72141) — ABC News, 2026-09-24
- [FDA panel endorses Grail’s first-of-its-kind cancer blood test](https://mins.news/en/item/71879) — The Associated Press, 2026-09-24